Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Herbal Extracts, and Parallel Import Business. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, cosmetics, and dietary and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, enzymes, dermatologics, systemic corticoids, women's healthcare, pain treatment, and ophthalmologics under the Dekristol, Ampho-Moronal, and Prednisolut brands. In addition, the company provides hyperthermic medical devices under the bite away and Herpotherm names; food supplements under the Hübner brand; and Azedil, a nasal spray and eye drop product to treat acute hay fever symptoms. Further, it engages in the parallel import pharmaceutical business under the axicorp brand. Additionally, the company offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetic products under the ABAlife, Mediteanox, and Pomanox names. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
(source: Yahoo Finance)